Abstract
Anaphylaxis or significant hypersensitivity reaction is one of the most catastrophic potential complications of chemotherapy. There is a 2-5% risk of hypersensitivity with paclitaxel, a commonly used chemotherapeutic agent for various cancers. Three patients, who developed hypersensitivity to paclitaxel infusion, received docetaxel without allergic reactions. Docetaxel may therefore be an alternative treatment for patients with paclitaxel hypersensitivity. (C) 2000 Lippincott Williams and Wilkins.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 565-568 |
| Number of pages | 4 |
| Journal | Anti-cancer drugs |
| Volume | 11 |
| Issue number | 7 |
| DOIs | |
| State | Published - 2000 |
Keywords
- Allergic reactions
- Ovarian neoplasms
- Taxane
ASJC Scopus subject areas
- Oncology
- Pharmacology
- Pharmacology (medical)
- Cancer Research